Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 34.75%
March 31, 2026 30.74%
December 31, 2025 30.77%
September 30, 2025 31.01%
June 30, 2025 19.96%
March 31, 2025 35.17%
December 31, 2024 30.20%
September 30, 2024 34.58%
June 30, 2024 27.91%
March 31, 2024 28.71%
December 31, 2023 22.55%
September 30, 2023 32.22%
June 30, 2023 31.63%
March 31, 2023 28.55%
December 31, 2022 23.75%
September 30, 2022 26.66%
June 30, 2022 27.78%
March 31, 2022 30.85%
December 31, 2021 33.46%
September 30, 2021 34.32%
June 30, 2021 33.06%
March 31, 2021 37.35%
December 31, 2020 33.61%
September 30, 2020 40.45%
June 30, 2020 38.54%
Date Value
March 31, 2020 37.73%
December 31, 2019 35.98%
September 30, 2019 38.40%
June 30, 2019 36.30%
March 31, 2019 33.02%
December 31, 2018 35.15%
September 30, 2018 39.43%
June 30, 2018 38.24%
March 31, 2018 36.11%
December 31, 2017 31.38%
September 30, 2017 36.03%
June 30, 2017 35.70%
March 31, 2017 35.25%
December 31, 2016 31.64%
September 30, 2016 28.88%
June 30, 2016 25.57%
March 31, 2016 26.31%
December 31, 2015 28.64%
September 30, 2015 26.04%
June 30, 2015 27.84%
March 31, 2015 29.27%
December 31, 2014 30.48%
September 30, 2014 31.71%
June 30, 2014 28.98%
March 31, 2014 22.46%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Becton, Dickinson & Co. 46.46%
Abbott Laboratories 52.64%
AngioDynamics, Inc. 56.00%
Alphatec Holdings, Inc. 62.90%
AtriCure, Inc. 76.75%

Gross Profit Margin (Quarterly) Related Metrics